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Abstract. A  membrane-bound adhesive protein that 
promotes neurite outgrowth in brain neurons has been 
isolated from rat brain (Rauvala, H., and R. Pih- 
laskari.  1987. J.  Biol. Chem. 262:16625-16635).  The 
protein is an immunochemically distinct molecule with 
a  subunit size of ~  30 kD (p30).  p30 is an abundant 
protein in perinatal  rat brain,  but its content decreases 
rapidly after birth. 
In the present study the amino-terminal  sequence of 
p30 was determined by automated Edman degradations. 
A  single amino-terminal  sequence was found, which is 
not present in previously studied adhesive molecules. 
This unique sequence has a cluster of five positive 
charges within the first 11 amino acid residues:  Gly- 
Lys-Gly-Asp-Pro-Lys-Lys-Pro-Arg-Gly-Lys. Antisyn- 
thetic peptide antibodies that recognize this sequence 
were produced in a rabbit, purified with a peptide 
affinity column, and shown to bind specifically to p30. 
The antipeptide antibodies were used, together with 
anti-p30 antibodies, to study the localization of p30 in 
brain cells and in neuroblastoma cells as follows. (a) 
Immunofluorescence and immunoelectron microscopy 
indicated that p30 is a component of neurons in mixed 
cultures of brain cells.  The neurons and the neuroblas- 
toma cells expressed p30 at their surface in the cell 
bodies and the neurites.  In the neurites p30 was found 
especially in the adhesive distal tips of the processes. 
In addition the protein was detected in ribosomal par- 
ticles and in intracellular  membranes in a proportion 
of cells. (b) The antibodies immobilized on microtiter 
wells enhanced adhesion and neurite growth indicating 
that p30 is surface exposed in adhering  neural cells. 
(c) Immunoblotting showed that p30 is extracted from 
suspended cells by heparin  suggesting that a heparin- 
like structure is required for the binding of p30 to the 
neuronal cell surface. A  model summarizing  the sug- 
gested interactions  of p30 in cell adhesion and neurite 
growth is presented. 
HF.S]Or~ of neurons to other cells or to extracellular 
materials  is thought to play an important  role in the 
outgrowth  and  guidance  of neurites  (Letourneau, 
1975).  In  an  attempt to  identify  adhesive  molecules that 
might play a role in such phenomena, we have fractionated 
solubilized membranes from young rat brain and monitored 
the fractionations  with brain neurons (Rauvala et al.,  1987; 
Rauvala and Pihlaskari,  1987). These studies have resulted 
in the isolation  of an adhesive  molecule that has a subunit 
size of •  30 kD (p30). Due to its neuron-binding  and neurite 
outgrowth-promoting properties and the developmental reg- 
ulation of its content in brain tissue, p30 has been suggested 
to play a regulatory role in neuronal  growth (Rauvala  and 
Pihlaskari,  1987). 
To further characterize  the structural  and functional prop- 
erties of p30 and its possible relationship  to other adhesive 
and neurite-promoting  factors, we have analyzed the amino- 
terminal  amino acid sequence of p30 and produced antipep- 
tide antibodies that specifically detect this unique sequence. 
The  affinity-purified  antipeptide  and  anti-p30  antibodies 
have been used to stain cultured brain cells. These studies in- 
dicate that p30 is mainly associated to neurons in mixed cul- 
tures  of brain  cells.  The  p30 protein  and  its  lysine-rich 
amino-terminal  sequence are detected as  surface-exposed 
structures  in neuroblastoma cells and in brain neurons. 
Materials and Methods 
Isolation of  p30 
The p30 protein was isolated from membrane pellets of early postnatal rat 
brains (from 2 to '~10-d-old rats) as has been previously described (Rauvala 
and Pihlaskari, 1987).  Protein content of the isolated fractions was deter- 
mined with a Coornassie Brilliant Blue G-250 dye-binding assay (Bio-Rad 
Laboratories, Cambridge, MA). The degree of purity of the isolated protein 
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with Coomassie Brilliant Blue. 
A mino-Terminal Sequence A nalysis 
Automated Edman degradations were carried out with either a  gas-phase 
sequencer (model 470A; Applied Biosystems, Inc., Foster City, CA) or with 
a pulsed liquid-phase sequencer (Model 477A, Applied Biosystems, Inc.). 
The p30 protein was separated with a reducing 5-20% gradient SDS-PAGE 
(Laemmli, 1970) in the presence of 0.1 mM sodium thioglycollate (Hunka- 
piller et al.,  1983)  and transferred to a  glass fiber filter for sequencing 
(Aebersold et al., 1986). Electrophoretic transfer was carded out in 25 mM 
"Iris,  10 mM glycine, 0.5 mM dithiothreitol (DTT), pH 8.3,  at 100 V for 
3 h in ice bath. Alternatively, the SDS-PAGE was omitted, and the p30 pro- 
tein was sequenced directly after the isolation with heparin-Sepharose and 
Affi-Gel blue (Rauvala  and Pihlaskari,  1987). 
Synthesis of  Peptides 
Solid-phase synthesis (Barany  and Merdfield, 1979) of peptides I-III (see 
Table  I)  was carried out with an automated peptide synthesizer (model 
430A;  Applied Biosystems, Inc.).  The amino acid sequences were con- 
firmed by automated sequencing (see above). 
Production and Purification of  Antibodies 
Production of anti-p30 antibodies and their purification with the p30 poly- 
peptide transferred from SDS-PAGE to nitrocellulose have been previously 
described (Rauvala and Pihlaskari, 1987). The anti-p30 antibodies were ex- 
tracted from the protein band at pH 2.5 in the presence of 1 mg/ml of BSA, 
and neutralized immediately. They were used for Western blotting at the di- 
lutions 1:10-1:100 and for staining of the cells at the dilutions 1:2-1:10. 
Antipeptide antibodies were produced in a  rabbit immunized with the 
synthetic peptide I (see table I) after coupling with m-bromosuccinimide 
from the cysteine residue to keyhole limpet hemocyanin (10 gmol of  peptide 
coupled to  10 mg of protein; Green et al.,  1982).  The antibodies were 
purified with affinity chromatography using peptide II coupled from car- 
boxyl groups with N-ethyl-N'-(3-dimethylaminopropyi)-carbodiimide  (Sig- 
ma Chemical Co., St.  Louis, MO; the reagent was used at 20 mg/mi in 
the coupling) to aminohexyl-Sepharose (Pharmacia Fine Chemicals, Upp- 
sala, Sweden). About 5 Ixmol of peptide II were coupled to 1 ml of swollen 
gel at pH 4-5  for ,~20 h  at room temperature. The gel was alternately 
washed with 0.1 M sodium acetate, 0.5 M NaCI, pH 4, and with 0.2 M so- 
dium bicarbonate, 0.5 M  NaCI,  pH 8.3  (four times with each buffer) to 
block excess amino groups, and was then used for purification of the anti- 
bodies. Serum (4 mill ml of swollen gel) was diluted with an equal volume 
of 1 M NaCI and adsorbed to the column for 3 h at room temperature or 
for ~20 h at 4°C. The mixture was centrifuged, and the Sepharose pellet 
was resuspended in PBS (137 mM NaCI, 27 mM KCI, 8.1 mM Na2HPO4 
and 1.5 mM KH2PO4, pH 7.4;  10 ml per 1 ml of swollen gel). Washing and 
centrifuging in PBS was repeated three times, and the Sepharose was further 
washed three times in the same way in 0.5 M NaCI in PBS. The Sepharose 
was then packed to a column, which was washed with PBS, and the bound 
antibodies were eluted with 50 mM glycine-HCl, pH 2.0. The fractions were 
immediately neutralized with 1 M Na2HPO4 (three drops per 1 ml). The 
antibodies were mostly eluted in one column volume of the eluting buffer, 
which was routinely used as the solution of antipeptide antibodies. Protein 
content of the fractions was determined with the Coomassie Brilliant Blue 
G-250 binding test (Bio-Rad Laboratories). The antibodies were character- 
ized with SDS-PAGE, with ELISA assays (Engvall,  1980)  using the p30 
protein coated to polystyrene microtiter wells, and with Western blotting ex- 
periments (Towbin et al., 1979).  They were used for immunoblotting at the 
concentrations of 0.1-1.0 gg/ml and for cell staining at  1-10 gg/ml. 
Cells and Cell Culture 
Cells from the N18 neuroblastoma clone were cultured on ordinary tissue 
culture  dishes  in  DME  (Flow  Laboratories,  Inc.,  McLean,  VA)  sup- 
plemented with 10% FCS, 100 U penicillin G/ml, and 0.1 mg streptomy- 
cin/ml in the atmosphere of 5% COff95% air.  Brain cells of the rat were 
prepared from 17-19-d-old embryos essentially as has been described (Yavin 
and Yavin,  1974).  Briefly,  cerebral hemispheres of the embryos were dis- 
sected in DME containing 10% FCS, 100 U/mi of penicillin G, 0.1 mg/mi 
of streptomycin, and 6 mg/ml of glucose. The cells were then dispersed in 
the serum-containing medium by pressing through a nylon mesh with 106 
gm pores. Culture wells for the brain cells were prepared by coating the 
tissue culture dishes with 5  gg/ml of poly-tAysine in water (Yavin and 
Yavin,  1974) followed by washing and further coating for 0.5 h with 10% 
FCS in DME (see above). The dispersed brain cells adhered nearly quan- 
titatively to such surfaces, as has been previously shown (Yavin and Yavin, 
1974). The medium was changed after '~20 h, and the adherent cells were 
used for the experiments within 2 d, if not otherwise indicated. Immuno- 
fluorescence studies (see below) using monoclonal antineurofilament, an- 
tiglial fibrillary acidic protein, and antivimentin suggested that '~80-90% 
of these cells were neurons, and the rest of them were mainly astrocytes. 
The proportion of astrocytes increased strongly, when the cells were kept 
in culture for ~1  wk. 
Fluorescence Microscopy 
Adherent cells on glass coverslips were fixed with 4% paraformaldehyde in 
Ca- and Mg-containing PBS (0.7 mM CaCI2,  0.5  mM MgCI2),  pH 7, for 
15 min at room temperature, washed with PBS, and used for membrane 
staining. Alternatively, membrane staining was carried out using adherent 
live cells. Adherent cultures fixed with methanol at  -20°C were used for 
the staining of permeabilized cells. Antineurofilament, antiglial fibrillary 
acidic protein, and antivimentin were used according to the manufacturer's 
guide (Labsystems Inc., Helsinki, Finland) and the antipeptide and anti-p30 
antibodies as indicated in each experiment. After washing with 5 or 10 mg/ml 
of BSA  in  PBS,  the  cells  were  overlaid  with  FITC-conjugated  swine 
anti-rabbit Ig or with rhodamine-conjugated rabbit anti-mouse Ig (DAKO- 
PATTS, Copenhagen; diluted  1:50 in 5  mg/ml of BSA in PBS), and in- 
cuhated as indicated in each experiment. After three washes with PBS, the 
coverslips were mounted on slides, which were studied with a Zeiss micro- 
scope (model IM35) equipped for epifluorescence with appropriate filters 
to specifically detect the FITC or rhodamine staining. 
Membrane staining of live ceils in suspension was carried out at 0--4°C 
essentially as has been described (Goding, 1983).  Briefly,  adherent cells 
were washed three times with Ca- and Mg-free PBS and incubated in the 
PBS at 37°C for ~30 min. The cells were dispersed by gentle pipetting, and 
washed in the PBS. The cell suspensions were allowed to cool in ice bath, 
and they were then incubated for 90 min with the antibodies, washed and 
incubated for 60 min with FITC anti-rabbit Ig (1:50; DAKOPATTS). After 
washing, the cells were centrifuged to slides and studied with phase-contrast 
and fluorescence microscopy. 
Immunoelectron Microscopy 
Brain cells dispersed from 17-19-d-old  rat embryos were allowed to adhere 
to poly-L-lysine-coated  tissue culture dishes (see above). They were washed 
three times with PBS, fixed with 1% glutaraldehyde for 5 rain at room tem- 
perature, and washed with PBS. The cells were then incubated with 20% 
normal swine serum (DAKOPATTS) in PBS for 20 rain at room temperature 
to block nonspecific binding of the link antiserum.  Incubation with the 
affinity-purified anti-p30 antibodies (1:10 in PBS) was then carded out at 
4°C for 48 h. The peroxidase/antiperoxidase method was used as described 
in  detail  (Panula et al.,  1981). Shortly,  unlabeled swine anti-rabbit Ig 
(DAKOPATTS) and the soluble complex of horseradish peroxidase/rabbit 
anti-horseradish peroxidase (DAKOPATTS) were diluted 1:100 in PBS and 
the incubations were carded out for 1 h at room temperature. The cultures 
were postfixed with 1% osmium tetroxide, dehydrated in a graded ethanol 
series, and embedded in an Epon-Araldite mixture. Ultrathin sections were 
viewed and photographed without poststaining in a JEOL 100s electron mi- 
croscope at 60 kV. 
Assays of CeU Adhesion and Neurite Outgrowth 
Adhesion assays using neuron-enriched brain cells that had been metaboli- 
cally labeled with a  mixture of ~4C-amino acids were carded out as de- 
scribed (Rauvala  and Pihlaskari,  1987). 
The NI8 neuroblastorna cells were dispersed for neurite outgrowth assays 
by incubating the cultures for ",30 rain at 37°C in the Ca- and Mg-free PBS 
and washed in the same buffer. The cells were assayed for neurite outgrowth 
in microtiter wells (Titertek  ®  multiwell plates; Flow Laboratories, Inc.) es- 
sentially as described (Rauvala,  1984).  The assays on the different coated 
surfaces were carried out  in  PBS  containing 0.7  mM  CaCI2.  0.5  mM 
MgCI2,  and 4.5 mg/ml glucose at the cell density of 1.25  x  105/ml (150 
gl of cell suspension per well; 67,000  cells/cm2). Assays with rat brain 
neurons were carded out in the serum-free DME as described (Rauvala and 
Pihlaskari,  1987). 
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Amino-Terminal Sequence Analysis 
Two approaches were used for sequence analysis. In one 
method p30 was separated on SDS-PAGE and transferred to 
activated glass fiber filter for sequencing (Aebersold et al., 
1986).  In the other method the SDS-PAGE was omitted and 
the  isolated protein was analyzed directly. Both methods 
gave a single and identical amino acid sequence: Gly-Lys- 
Gly-Asp-Pro-Lys-Lys-Pro-Arg-Gly-Lys-Met-Ser-X-Tyr- 
Ala-Phe-Phe-Val-Gln.  No clear assignment was obtained for 
position 14, which is indicated by X. The amount of recov- 
ered amino acid derivatives corresponded to the amount of 
protein loaded on the sequencer. 
Production and Characterization  of 
Antipeptide Antibodies 
Purification of antibodies obtained by immunizing with p30 
(designated anti-p30) has been previously reported (Rauvala 
and Pihlaskari, 1987). The p30 polypeptide transferred from 
SDS-PAGE to nitrocellulose was used for the purification of 
these antibodies. 
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Figure 1. Binding of antipeptide antibodies to p30 in ELISA assays. 
The rabbit was immunized with 1 mg of peptide I/keyhole limpet 
hemocyanin  conjugate in complete Freund's adjuvant. The immune 
serum was taken after two 1-mg booster injections given in incom- 
plete Freund's adjuvant (~6 wk after the primary immunization). 
Affinity  purification of the antibodies was carded out with peptide 
II coupled to aminohexyl-Sepharose  (see Materials and Methods). 
The sera and the affinity-purified  antibody (100-1xl vol) were tested 
for binding to 1 lag of p30 (coated in 100 Ixl of PBS to microtiter 
wells that were postcoated with 1 mg/ml of BSA). Binding of the 
antibodies to the wells was assayed  with alkaline phosphatase-con- 
jugated anti-rabbit IgG. Alkaline phosphatase was determined with 
paranitrophenyl phosphate measured in microtiter wells. 
An intense immune reaction (Fig. 1) was observed in one 
rabbit immunized with the synthetic peptide I (Table I) cou- 
pled from the cysteine residue to keyhole limpet hemocyanin 
(Green  et  al.,  1982).  This  peptide  is  different from the 
amino-terminal sequence of p30 in one amino acid residue 
(No. 9), but the antibody was shown to bind to p30 (Fig. 1) 
and was therefore further studied. 
The antipeptide antibody could be purified with peptide II 
(lacking the carboxy-terminal cysteine used for coupling to 
keyhole limpet hemocyanin and not found in p30) coupled 
with carbodiimide to aminohexyl-Sepharose. About 40 ~tg of 
antibody was purified from 1 ml of immune serum.  The 
purified antipeptide antibody gave one major band with Mr 
of 'x'50 kD and a minor band with Mr of •  25 kD in SDS- 
PAGE stained with Coomassie Brilliant Blue. Immunoblot- 
ting indicated that the major band is the heavy chain of im- 
munoglobulin (not shown). The peptide affinity column thus 
isolates essentially pure immunoglobulin in one single step. 
The purified antibody (designated antipeptide) detected p30 
in ELISA (Fig. 1) and in Western blotting using the purified 
p30, SDS-solubilized rat brains or SDS-solubilized N18 neu- 
roblastoma cells (Fig. 2, A-C). Binding of the antibody to 
the p30 band was completely blocked by the HPLC-purified 
peptides II and III (Fig. 2 D). The inhibition by peptide III 
(having the same sequence as p30) was observed at the same 
concentrations (10-100  ~tM peptide) as by peptide II (used 
for affinity purification). Thus, the arginine (residue No. 9) 
is not critical for the recognition by the antipeptide antibody. 
In  contrast to  the antipeptide antibody, binding of the 
anti-p30 antibody (obtained by immunization with p30 over 
a period of many months) to the p30 band was not blocked 
or reduced by the synthetic peptides (not shown). Thus, the 
amino-terminal sequence of  p30 is not a major immunogenic 
site in the p30 molecule. It is apparent that the binding of the 
anti-p30 antibodies to p30 does not depend on the conforma- 
tion of p30, because these antibodies were purified with the 
denatured polypeptide. The peptide sequences recognized by 
the anti-p30 antibodies have not been further characterized. 
Fig. 3 shows that the purified antipeptide antibody is able 
to inhibit the adhesive effect of p30 under the conditions that 
favor binding of the antibody to p30 instead of the plastic 
culture substrates (coating of the plastic substrates with the 
antibodies enhances adhesion, see below). Inhibition of the 
adhesive effect of  p30 with the affinity-purified  anti-p30 anti- 
body has been shown in the previous study (Rauvala and Pih- 
laskari, 1987).  Thus, both the antipeptide and the anti-p30 
antibodies detect an adhesive molecule. 
Staining of CeUs with the Antibodies 
The N18 neuroblastoma cells cultured on glass coverslips 
and fixed shortly with paraformaldehyde  were clearly stained 
with the antipeptide antibodies at the protein concentration 
Table L Synthetic Peptides Used in the Study 
Peptide  Sequence 
I  Gly-Lys-Gly-Asp-Pro-Lys-Lys-Pro-Ser-Gly-Lys-Met-Ser-Cys 
II  Gly-Lys-Gly-Asp-Pro-Lys-Lys-Pro-Ser-Gly-Lys 
III  Gly-Lys-Gly-Asp-Pro-Lys-Lys-Pro-Arg-Gly-Lys 
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ing specific binding of anti-p30 
and antipeptide antibodies to p30. 
(A) Amido black staining of the 
samples transferred from 5-20% 
reducing SDS-PAGE to nitrocel- 
lulose. Lane 1, 1.5 gg of purified 
p30; lane 2, 25 ~tl of SDS-solubi- 
lized  N18  neuroblastoma  cells 
(~100 mg of cells  were solubi- 
lized for 0.5 h at 100°C in 2.5 ml 
of reducing SDS gel buffer); lane 
3,  25  gl of SDS-solubilized rat 
brain (100 mg of brain from 17- 
19-d-old rat embryos were solubi- 
lized for 0.5 h at 100°C in 2.5 ml 
of reducing SDS  gel buffer).  B 
and  C show replicas  containing 
samples as in A, lanes 1-3. B was 
stained with anti-p30  antibodies 
(1:100). C was  stained with the 
afffinity-purified  antipeptide anti- 
body (0.2 ~tg/ml). (D) Each lane 
contained 1.5 ~tg of p30. Lane 1, 
staining with 1 vg/ml of affinity- 
purified antipeptide  antibody; lane 
2, staining as in lane 1 in the pres- 
ence of 10 lxM peptide II (see Ta- 
ble I); lane 3, staining as in lane 
1 in the presence of 10 ~tM pep- 
tide III. Transfer  of  the proteins to 
all lanes was controlled  by staining 
with Ponceau S. before  other stain- 
ing procedures. Marker proteins: 
BSA (66 kD), ovalbumin  (45 kD), 
glyceraldehyde-  3-phosphate dehy- 
drogenase (36 kD), carbonic an- 
hydrase  (29  kD),  and  soybean 
trypsin inhibitor (20 kD). 
1-10  ~tg/ml  (Fig.  4).  Membrane staining was  observed in 
most cells in both the cell bodies and the neuritic processes. 
The proximal parts of the neurites often lacked the staining, 
whereas the distal adhesive tips were clearly stained (Fig. 4). 
Staining of the cells could not be inhibited by 20% nonim- 
mune swine serum used in some experiments instead of BSA 
(Fig. 4) to block nonspecific binding of the antibody to the 
cells.  The staining pattern was  similar when the antibody 
was incubated with the cells for ",~20 h at 4°C or for 1 h at 
room temperature. The surface staining of both the parafor- 
maldehyde-fixed N18 cells and the brain cells could be in- 
hibited by  100 IxM synthetic peptide,  shown for the brain 
cells in Fig. 5, a-d. Specificity of the membrane staining was 
also suggested by the finding that nonimmune rabbit IgG (10 
~tg/ml) did not stain the cell surface. 
Adherent live cells could be also stainext with the antipep- 
tide antibody (Fig. 4, e-h), but it was difficult to retain the 
extended morphology of the neurites during the staining pro- 
cedure. Thus, the neurites apparently retract during staining 
on ice bath giving rise to multiple varicosity-type forma- 
tions, which were not seen before the staining procedure or 
in the cells stained after short fixation with paraformalde- 
hyde (Fig. 4, a-d). However, the surface staining of adherent 
live cells is also seen in both the cell bodies and the neurites 
(Fig. 4, e-f). The patchy staining outside the cells (Fig. 4 
f) probably corresponds to the substrate-attached material 
left behind by the moving cells. The adherent live cells were 
stained  with the anti-p30  antibody  in  a  similar  way  (not 
shown). 
Fig.  5  shows  that also  the  adherent brain  cells can be 
specifically stained with the antipeptide antibody. As in the 
neuroblastoma cells, the staining was found in both the cell 
bodies and the neurite-type processes, especially the varicos- 
ities of the neurites (Fig.  5, a-b).  The cell bodies and the 
processes of these cells were also stained by monoclonal an- 
tineurofilament antibodies after permeabilization with meth- 
anol (not shown). 
In addition to adherent cells, p30 is found at the surface 
after the cells have been suspended using Ca- and Mg-free 
PBS. Fig. 6 shows an example of staining of live cells in sus- 
pension using the anti-p30 antibody. In controls, in which 
the first antibody was omitted, only some broken cells were 
fluorescent. 
Immunoelectron microscopy detected p30 on the plasma 
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Figure 3. Inhibition of brain cell adhesion to p30-coated  surfaces 
by  the  affinity-purified  antipeptide  antibody.  Polystyrene  wells 
(Greiner,  3.5  cm diam)  were  coated  with 4  I.tg/ml of p30  (750 
~tl vol) at 4°C for ,~20 h. The wells were washed with PBS and 
incubated with 1 mg/ml of BSA (crystalline BSA, essentially glob- 
ulin-free, Sigma Chemical Co.) in PBS or with the indicated con- 
centrations of immunoglobulins in the BSA-containing buffer (750 
~tl vol; BSA was used to inhibit coating of the plastic with the anti- 
bodies). The nonimmune immunoglobulin was purified from rabbit 
serum with protein A-Sepharose  and was of similar purity as the 
antipeptide  immunoglobulin (that also binds to protein A-Sepha- 
rose),  as assessed with SDS-PAGE stained with Coomassie Blue. 
After 1 h incubation at room temperature with the BSA-PBS buffer 
or the antibodies, the wells were washed two times with PBS, and 
the brain cells were incubated on the wells (52,000 ceUs/cm  2) for 
30 min at 37°C. The wells were washed, rotated on an orbital shaker 
at 140 rpm for 3 min, washed, and estimated for cell binding with 
phase-contrast microscopy. Quantification of cell binding was based 
on the counting of ~4C-amino  acid label from the solubilized cells. 
The error bars indicate the range of duplicate determinations. 
membranes of both cell bodies (Fig.  7  a) and of neuritic 
processes (Fig. 7, c-e). Intensely stained structures were ob- 
served  in  areas  of membrane-membrane contact  (Fig.  7, 
c-e).  Intracellular cytoplasmic staining  was seen in many 
cells. The intensity of the intracellular staining varied from 
moderate to intense, and its location suggested association to 
polyribosomes (Fig. 7 b). Intracellular staining was also seen 
in cross sections (Fig. 7 c) and in longitudinally cut sections 
(Fig.  7  d)  of cellular  processes,  which  were  in  addition 
stained on the plasma membranes. In some processes the 
staining was confined to the plasma membrane (Fig.  7  e). 
The results were similar when either anti-p30 or antipep- 
tide antibodies were used, but no staining was observed when 
the primary antibodies were omitted.  However, binding of 
the antipeptide antibody to p30 was strongly reduced when 
the protein was treated with glutaraldehyde used as the fixing 
reagent in the staining method (not shown). The anti-p30 an- 
tibodies were therefore mainly used in the immunoelectron 
microscopy. 
Neurite-promoting Effect of the 
Immobilized Antibodies 
To study whether the p30 protein is surface exposed in living 
adhering cells, the effect of the immobilized antibodies on 
cell behavior was tested. Fig. 8 shows that the immobilized 
antipeptide antibody has a dramatic effect on the morphology 
of neuroblastoma cells. Extensive neurite initiation with flat- 
tened growth cones is observed in a 3-h assay. This effect is 
clearly more pronounced than that of  p30 itself for the neuro- 
blastoma cells. In an assay of 20 h, the effect of p30 on the 
neuroblastoma cells is already clearly observed, but the out- 
growth  of neurites  is  still  more pronounced  on  surfaces 
coated with the antipeptide antibody. In contrast to the neu- 
roblastoma cells,  rat brain neurons favor p30 over the an- 
tipeptide antibody,  although this also has some effect (not 
shown). 
The effect of the antipeptide antibody was reduced by the 
synthetic  peptide  (Fig.  8),  which  did  not  inhibit  neurite 
growth on laminin when tested at the same concentrations. 
However, the peptides also have some effects of their own on 
neuronal adhesion (not shown), which jeopardizes interpre- 
tation of the results. The effects of the peptides synthesized 
according to the p30 sequences thus require further studies 
before they can be evaluated in a more detailed way. Speci- 
ficity of the effect of the antipeptide antibody was clearly in- 
dicated by experiments, in which its effect was compared to 
that of nonimmune immunoglobulin of similar purity. The 
antipeptide antibody was similar to the purified nonimmune 
immunoglobulin in that it was quantitatively bound to protein 
A-Sepharose (not shown). A difference of several orders of 
magnitude was observed (Fig. 9) when the dose-response re- 
lationships of the two immunoglobulins for neurite initiation 
were studied.  In agreement with this finding, the Fab frag- 
ments of the antipeptide antibody had the same effect as the 
native antibody. The anti-p30 antibody had a similar effect 
on the cells as the antipeptide antibody (not shown), but it 
has been only purified as dilute solutions in the presence of 
BSA, which has prevented a more detailed characterization 
of the effect. 
Extraction of  p3O  from Suspended Cells by Heparin 
The isolated molecule p30 binds to heparin-Sepharose rather 
strongly, and is eluted from the column at 0.75-1.0  M  NaCI 
in salt gradients (Rauvala and Pihlaskari,  1987).  The pos- 
sibility was therefore studied that p30 also binds to a hepa- 
rinlike structure in living cells. We observed that p30 can be 
displaced from living brain cells by heparin. In the immuno- 
blotting experiment shown in Fig.  10 A, the amount of p30 
released from the cells to the supernatant was found to be 
comparable to that released by SDS,  whereas the amount 
released to PBS (with or without Ca and Mg) was low or un- 
detectable.  Some detachment of p30 probably occurred in 
the presence of 1 mM EDTA (Fig.  10 A). Fig.  10 B shows 
Rauvala et al.  The Adhesive Molecule p30  2297 Figure 4. Indirect immunofluorescence  staining of N18 neuroblastoma cells by the afffinity-purified antipeptide  antibody. Phase-contrast 
microscopy (a, c, e, and g) and fluorescence microscopy (b, d,f, and h) of the respective fields. (a-d) The cells grown on glass coverslips 
were fixed with 4% paraformaldehyde  in PBS, pH 7, for 15 min at room temperature,  washed with PBS, and incubated for 0.5 h with 
5 mg/ml of BSA in PBS. The cells were then incubated for ,°20 h at 4°C with 10 I.tg/ml  of the antipeptide antibody in the BSA-PBS buffer 
(a and b) or without the first antibody in the BSA-PBS (c and d). An intense staining is seen in cell bodies and in the distal tips of neuritic 
processes  (arrowheads). (e-h) Staining of live cells on ice bath. The cells were washed with PBS, incubated for 60 min with 10 mg/ml 
The Journal of Cell Biology, Volume 107. 1988  2298 Figure 5.  Indirect immunofluorescence staining of brain cell cultures with the antipeptide antibody. Phase-contrast microscopy (a and c) 
and fluorescence microscopy (b and d) of the respective fields. The cells dispersed from the hemispheres of 17-19-d-old rat embryos were 
cultured for 4 d on poly-L-lysine-coated glass coverslips and fixed with 4 % paraformaldehyde in PBS, pH 7, for 15 min at room temperature. 
The fixed cells were washed with PBS and incubated for 1 h at room temperature with 20% nonimmune swine serum in PBS. The cells 
were then incubated for 1 h at room temperature  with  10 I.tg/ml of the antipeptide antibody in the swine serum-PBS in the absence (a 
and b) or presence  (c and d) of 100 I~M synthetic peptide III (Table I). The peptide was preincubated for 1 h with the antibody before 
the mixture was applied to the cells. The arrowheads point to neurites. The cell bodies and the varicosities of  the neurites are clearly stained, 
and this staining is inhibited by the lysine-rich amino-terminal  peptide.  Bar, 50 ~tm. 
that heparin concentrations of 1.0 and 0.25 mg/ml released 
p30,  whereas 0.1  mg/ml of heparin was rather ineffective. 
The low molecular weight heparin was more effective than 
heparin on weight basis. Thus, 0.1 mg/ml of low molecular 
weight heparin still effected an apparently maximal release 
from the cells (Fig.  10 B). Fig.  10 C shows that dextran sul- 
fates (especially those of higher molecular weight) were also 
able to release p30, whereas the chondroitin sulfates used (4 
mg/ml of chondroitin sulfate from whale or shark cartilage) 
or colominic acid (polysialic acid; 4 mg/ml) did not release 
p30  from the brain cells.  In addition  to some polyanionic 
substances  shown in  Fig.  10  C,  the  following compounds 
(tested at 4 mg/ml) did not extract p30 from the brain cells: 
polyadenylic acid, poly-L-glutamic acid (degree of polymer- 
ization 20,000),  and poly-L-glutamic acid (degree of poly- 
merization  21,000).  Thus,  sulfate-containing  polyanionic 
substances,  especially  heparin-like  structures,  appear  to 
release p30  from the  cells.  A  high  polymeric size is  not 
necessarily needed, but depolymerized heparin (mol wt of 
4,000-6,000)  also displaces p30 from the cells. 
Discussion 
In a previous study (Rauvala and Pihlaskari,  1987) the hepa- 
of BSA in PBS on ice bath and then for 90 min with  10 ~tg/ml of the antipeptide antibody in the BSA-PBS in the absence (e and f) or 
presence (g and h) of 100 ~tM synthetic peptide III (Table I). The peptide was preincubated for 1 h with the antibody before the mixture 
was applied to the ceils. A respective inhibition of the antibody with the synthetic peptides is shown in a Western blotting experiment in 
Fig. 2 D. Bars,  50 lam. 
Rauvala et al. The Adhesive Molecule  p30  2299 Figure 6. Indirect immunofluorescence staining of live N18 neuro- 
blastoma cells (a and b) or live rat brain ceils (c-f) in suspension. 
Phase-contrast microscopy (a, c, and e) and fluorescence micros- 
copy (b, d, and f) of the respective fields. The anti-p30 antibodies 
extracted from the p30 band (1:2) were incubated for 90 min with 
the cells in ice bath. A patchy cell surface staining is observed in 
both the neuroblastoma cells (a and b) and the brain cells (c and 
d). The staining was not observed in cells incubated without the 
first antibody (shown for the brain cells in e and f). Bar, 50 ~trn. 
rin-binding protein p30 was isolated from cell membranes of 
rat brain. Because p30 binds efficiently  brain neurons and in 
addition enhances neurite growth in these cells, it has been 
called an adhesive molecule. The inference that p30 has a 
role  in  a  developmental process  in  brain  as  an  adhesive 
and/or  growth-promoting molecule has  been further sup- 
ported by the finding that  it is abundantly present in  the 
perinatal brain of rat, but the content is rapidly decreased af- 
ter birth (Rauvala and Pihlaskari,  1987). 
P30 was isolated as an immunochemically distinct mole- 
cule suggesting that the subunit 30-kD polypeptide is not a 
fragment of a previously characterized adhesive or growth- 
promoting  polypeptide of higher  molecular  weight.  The 
amino-terminal sequence analyzed in the present study con- 
firms this inference. Thus, this sequence is not found in a 
computer homology search (DNASIS of LKB containing the 
sequences of Protein Identification Resource, data base R 
12.0,  dated March  1987).  The most clearcut similarity.is 
found in a viral nucleoprotein (Herr, 1984) that has the same 
Six-amino acid sequence (Pro-Lys-Lys-Pro-Arg-Gly),  but is 
otherwise a clearly different protein as compared to p30. 
The extracellular glycoprotein laminin (T'mapl et al., 1979) 
is a neurite-promoting molecule (Baron van Evercooren et 
al.,  1982; Manthorpe et al., 1983; Rogers et al.,  1983) and 
might give a cell-active fragment in the isolation procedure. 
In fact, the heparin-binding fragment of laminin is known to 
enhance neurite growth (Edgar et al.,  1984). However, the 
amino-terminal sequence of p30 is not similar to published 
laminin sequences in computer homology searches, and it is 
not found in the recently published sequences of laminin 
(Pikkarainen et al., 1987; Sasaki et al., 1987), The data base 
used in computer homology searches contains the fibronec- 
tin sequences, but the amino-terminal sequence of  p30 is not 
similar to any of these sequences. The sequences of the neu- 
ral cell adhesion molecule (Barthels et al.,  1987;  Cunning- 
ham et al., 1987) do not either contain the p30 sequence ana- 
lyzed in this study.  The p30 protein also appears different 
from basic fibroblast growth factor that has various growth- 
promoting effects when tested with neural cells (Schubert et 
al.,  1987; Unsicker et al.,  1987). Western blotting of SDS- 
solubilized N18 cells and embryonic rat brain (Fig. 2, A-C) 
further supports the idea that p30 is a  distinct novel mol- 
ecule. 
The sequence data were used to synthesize peptides (Table 
I) for the production of antibodies. An antisynthetic peptide 
antibody was affinity purified and shown to bind to p30 in 
ELISA assays (Fig.  1), Western blotting experiments (Fig. 
2), and in cell adhesion assays (Fig. 3). These experiments 
confirm that the amino-terminal sequence described in this 
study derives from the adhesive molecule p30. 
The N18 neuroblastoma cells were previously shown to ex- 
press p30 (Rauvala and Pihlaskari, 1987) and were therefore 
used to study the cellular localization of this molecule. The 
neuroblastoma cells can be regarded as "autonomous" with 
respect to the substrate required in neurite growth, although 
the rate of neurite growth in these cells can be enhanced by 
certain proteins, especially laminin (Jousimaa et al.,  1984; 
Rauvala et al., 1987). Thus, the neuroblastoma cells are able 
to initiate and extend neurites even on an inert or artificial 
surface (Seeds et al.,  1970; Schubert et al.,  1971). Interest- 
ingly, in the neuroblastoma cells grown on glass the antipep- 
tide antibody stains the surface in the cell bodies and in the 
distal growth cone-like parts of the neurites (Fig. 4, a-b). 
This localization is consistent with the adhesive function of 
p30, because the growing neurites are known to adhere to ex- 
ternal  surfaces  with  their distal  tips  (Letourneau,  1975). 
Thus, the adhesive molecule p30 might function in an "auto- 
crine manner" in neurite growth: the protein produced by the 
cell is secreted in the growth cone to facilitate adhesion and 
neurite growth on an external surface. Immunoelectron mi- 
croscopy (see below) is consistent with the proposal that p30 
is produced by the neurons and transported to the growth 
cone within the neurite.  Conversely, when the antipeptide 
The Journal of Cell Biology,  Volume 107, 1988  2300 Figure 7. Immunoelectron  microscopy of cell bodies and processes of rat brain ceils. Ceils were dispersed  from 17--19-d-old  rat embryos, 
allowed to adhere to poly-L-lysine-coated  glass coverslips, and prepared for electron microscopy as descr,oed  in Materials and Methods. 
Attinity-purified anti-p30 antibodies (1:10) were used for staining, n, nucleus. (a) Two cells stained at their plasma membranes (arrowheads) 
and moderately  in cytoplasmic  structures.  (b) A higher magnification of the areas of cytoplasmic immunoreaction shows aggregation of 
the reaction product in polyribosomes. (c) Cross sections of two heavily stained processes  making contact with a cellular process and an 
immunoreactive  cell. The process (p) has only plasma membrane immunoreaction  near the contact area (arrowheads).  (d) A longitudinal 
section of a process  (p) that displays immunoreaction both in cytoplasmic  structures  and at the plasma membrane (arrowheads).  (e) A 
cellular process in contact with a cell. Both are only stained at their plasma membranes (arrowheads).  Note the intense staining in several 
areas of membrane-membrane  contact in c-e. Bars:  (a and c-e) 500 nm; (b)  100 nm. 
Rauvala et al. The Adhesive Molecule  p30  2301 Figure 8.  Neurite outgrowth in N18 neuroblastoma cells on a surface coated with  10 ~tg/ml of the affinity-purified antipeptide antibody. 
The cells were incubated for 3 h at 37"C on the antibody-coated surfaces (67,000 cells/cm 2) in the absence (a) or presence (b) of 400 ~tM 
synthetic peptide, fixed with 2% glutaraldehyde and stained with 0.1% toluidine blue. The HPLC-purified peptide II (Table I) was dissolved 
in PBS and passed through a Sephadex G-25 column in PBS before it was diluted in the assay medium. It was allowed to bind to the antibody- 
coated surface for 1 h before the cells were added. The antibody coating was omitted in c; other conditions were as in a. Flattened growth 
cones are seen in several cells in a  (arrowheads).  Bar, 100 ~tm. 
antibody is immobilized on the substrate, the neuroblastoma 
cells respond in a dramatic way extending rapidly neurites 
that end in flattened growth cones (Figs. 8 and 9). Taken to- 
gether, these data suggest that the antipeptide antibody binds 
to an adhesive molecule of the cell surface that is involved 
in neurite growth. 
Culturing of embryonic brain cells for a  few days results 
in a characteristic structure, in which the neurons and the ag- 
gregates of neurons are connected to each other with neurites 
6O 
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Figure 9. Dose-response curves showing neurite outgrowth in NI8 
neuroblastoma cells on surfaces coated with the afffinity-purified  an- 
tipeptide  antibody or the nonimmune  immunoglobulin of similar 
purity. The cells were incubated for 3 h at 37°C on the different sur- 
faces (67,000 ceUs/cm  2) and fixed with glutaraldehyde.  The pro- 
portion of  cells having one or more neurites >10 gm long was calcu- 
lated for each concentration  of the immunoglobulins.  The results 
are expressed  as the  average value  +SD  from six  microscopic 
fields. Each microscopic field contained on the average 158 cells. 
and bundles of neurites, as has been shown before (Yavin and 
Yavin, 1974).  In this kind of mixed cultures neurons are fre- 
quently located on top of a cell monolayer consisting mainly 
of astrocytes (on the basis of staining with antiglial fibriUary 
acidic protein). Staining of the mixed brain cell cultures with 
the antipeptide antibody detects p30 mainly in neurons (Fig. 
5).  As in the neuroblastoma cells, p30 is found both in the 
cell  bodies  and  the  neurites.  The  varicosities  are  clearly 
stained in the neurites (Fig. 5, a-b). Immunoelectron micro- 
scopy suggests that p30 is clearly stained in the contact-form- 
ing areas of the processes (Fig. 7; see below). Thus, the lo- 
calization of p30 in neurons would appear to be analogous 
to that seen in the neuroblastoma cells. 
Two groups of stained cells are discerned by the anti-p30 
antibody used in  immunoelectron microscopy. In one cell 
type the staining is restricted to the plasma membrane, espe- 
cially in the areas of membrane-membrane contact, whereas 
in the other cell type the staining is seen in addition in intra- 
cellular  structures  (Fig.  7).  Immunofluorescence staining 
of live cells with the same antibody (the anti-p30 staining 
shown for suspended cells in  Fig.  6)  supports the  surface 
localization seen in electron microscopy. The intracellular 
stained structures would appear to be ribosomes and intra- 
cellular membranes in cells containing neurotubule-like struc- 
tures.  In the cells expressing neurites both the surfaces of 
neurites and the intracellular membrane structures of neu- 
rites are clearly stained (Fig. 7, c-e).  It would thus appear 
that p30  is  synthesized  in  neurons  and  transported  in  the 
growing neurite together with other newly synthesized mem- 
brane structures, which are known to be transported within 
the neurite to the growth cone where the transported vesicles 
fuse with the plasma membrane. However, the site of p30 
synthesis in different cell types in brain remains to be eluci- 
dated with in situ hybridization experiments. 
The Journal of Cell Biology, Volume  107, 1988  2302 Figure 10. Immunobloks showing the extraction of p30 from suspended brain cells by heparin and by low molecular weight heparin (mol 
wt of 4,000-6,000). The brain cells were extracted for 15 min at room temperature under different conditions, centrifuged, and the superna- 
tanks were separated on 5-20% gradient SDS-PAGE, transferred to nitrocellulose, and analyzed for binding of anti-p30 or antipeptide anti- 
bodies. Each lane corresponds to an extract from 1 x  106 cells. (A) Adherent brain cells cultured overnight on poly-L-lysine-coated tissue 
culture dishes were dispersed in Ca- and Mg-free PBS (see Materials and Methods) and washed in PBS. The suspended cells were extracted 
in PBS (lane 1 ), 1 mM EDTA in PBS (lane 2), 1 mg/ml heparin (Sigma Chemical Co.) in PBS (lane 3), or in the reducing SDS gel sample 
buffer (lane 4);  1 mM PMSF was added to all extraction buffers from a  100-mM solution in ethanol.  Detection,  anti-p30 (1:100). (B) 
The extractions were carried out essentially as in A, but the cells dispersed  from 17-19-d-old rat brain hemispheres  were only allowed 
to recover for 1 h in suspension before they were extracted. The extractions were carried out in PBS containing 0.1 mg/ml of BSA without 
PMSE Heparin was tested at 1 mg/ml (lane 1 ), 0.25 mg]ml (lane 2), and 0.1 mg/ml (lane 3); the concentration of low molecular weight 
heparin (mol wt of 4,000-6000;  Sigma Chemical Co.) was 0.1 mg/ml (lane 4).  Detection,  antipeptide (0.25 gg/ml).  (C) Extraction of 
brain cells dispersed from adherent cultures (the cells were cultured for 2 d after they had been dispersed from brain) with different poly- 
anions (Sigma Chemical Co.) at 4 mg/ml. Dextran sulfates with mol wt of 5,000 (lane 1), 8,000 (lane 2), and 500,000 (lane 3) are compared 
to heparin (lane 4), chondroitin sulfate from whale cartilage (lane 5), and colominic acid (lane 6). Immunoblotting of the purified p30 
(1.45 ltg) is shown as a standard (lane  7).  Detection,  anti-p30 (1:100). 
The antipeptide antibody immobilized on microtiter wells 
strongly enhances neurite growth in the neuroblastoma cells 
(Figs. 8 and 9) and to a lower extent in the brain cells. This 
finding is consistent with the immunofluorescence localiza- 
tion of p30 in the neuroblastoma cells (Fig. 4, a and b), and 
further  indicates  that  the  lysine-rich  amino-terminal  se- 
quence of p30 is surface exposed and available for adhesive 
interactions in living adhering cells. The data do not exclude 
the possibility that an antibody directed to another structure 
occurring at the surface of neurons and their growth cones 
would also enhance neurite growth. It is, however, notewor- 
thy that tens of different cell-binding surfaces have been pre- 
viously studied using this assay (Rauvala,  1984;  Rauvala et 
al.,  1987). Of these surfaces only laminin has a comparable 
neurite-promoting effect on the neuroblastoma cells. 
Fig. 11 envisions the effects of p30 (top) and of the antipep- 
tide antibody that binds to the amino-terminal sequence of 
p30 (bottom).  It is noteowrthy that p30 stays at the cell sur- 
face after the cells have been dispersed using Ca- and Mg-free 
PBS (Fig. 6). It was previously suggested that p30 is either 
an integral membrane component or associated to an integral 
membrane component (Rauvala and Pihlaskari,  1987). The 
latter possibility is depicted in Fig.  11 because p30 can be 
displaced  from suspended  cells by heparin-like  structures 
(Fig. 10). In cell contact with the substrate-bound p30 (Stage 
I, top of Fig.  11) the putative receptors of p30 are immobi- 
lized (Stage II), which initiates neurite growth (Stage III). In 
the  bottom  of Fig.  11  the  substrate-bound  antibody  acts 
through  the  same  receptors  by  binding  to  the  receptor- 
associated p30. The extent to which different cells would re- 
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Figure 11. A schematic model for 
the interaction of neuronal cells 
with  immobilized p30  (top)  or 
with  the  immobilized  antibody 
that binds to the lysine-rich  amino 
terminal  sequence of p30  (bot- 
tom). Cells dispersed for the assay 
contain  surface-associated  p30 
(shown in Fig. 6) that binds to an 
integral membrane component  (re- 
ceptor of  p30). P30 coated on the 
culture  surface  immobilizes the 
surface receptors (Stage  II), which 
triggers neuritic growth. In this 
step the substrate-bound  p30 binds 
to free receptors, but it may also 
bind to p30 associated to the cell 
surface receptors. This possibility 
(a homophilic binding mechanism) is suggested by the finding that p30 forms polymeric structures (Rauvala and Pihlaskari, 1987). P30 is 
depicted as a dimer in the model, although higher polymeric forms may also occur. The immobilized antibody stimulates the cells through 
the same sequence of components by binding to the cell surface-associated p30. 
spond either to the substrate-bound p30 or the substrate- 
bound antibody might depend, at least in part, on the degree 
of occupancy of the receptors by p30 (see Fig.  11). 
The cell staining experiments (Figs. 4-7), the neurite out- 
growth experiments (Figs. 8 and 9), and the heparin extrac- 
tion experiments (Fig.  10) indicate that p30 and its lysine- 
rich amino-terminal sequence are associated to the surface 
of neural cells and are available for adhesive interactions. It 
is worth noting that synthetic poly-L-lysine has been known 
for a long time to be essential for the survival of central ner- 
vous  system neurons  in  tissue  culture  (Yavin  and  Yavin, 
1974). The adhesive molecule p30 and its lysine-rich amino- 
terminal sequence may represent a physiological analogue of 
poly-L-lysine. We have recently constructed a Lgtll expres- 
sion library using mRNA of perinatal rat brain and isolated 
using the antipeptide antibody, a eDNA clone that encodes 
the amino-terminal part of p30 (Merenmies, J., and H. Rau- 
vala, unpublished results). The deduced amino acid sequence 
of this clone contains a sequence that exactly matches with 
the amino-terminal peptide reported in this study. Further- 
more, the lysine-rich sequence of p30 contains at least ~60 
amino acids in the amino-terminal part of the molecule (ly- 
sine plus arginine comprise 25 % of the amino acids in this 
sequence). Elucidation of the whole sequence of p30 is un- 
der way, and should give the possibility to study the various 
peptide sequences of p30 for their effects on neurons. 
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Note Added in Proof: After this study was completed, the amino-termina/ 
sequence that we report for p30 was found in a computer search (Swiss-prot 
protein sequence data bank, May 1988). This sequence and the sequences 
of the isolated eDNA clones (Merenmies, J., and H. Rauvala, unpublished 
results) closely correspond to the primary structure of the high mobility 
group protein 1 (HMG 1) that has been previously studied as a DNA-binding 
protein. The adhesive and heparin-binding properties of this protein (Figs. 
3 and 10) as well as its localization in the extracellular and cytoplasmic com- 
partments  (Figs.  4-11)  strongly  suggest that  extranuclear  mechanisms 
should be considered as the basis of the role of p30 in cell growth. 
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